Drug intelligence / Profile preview

eucalyptus oil

Development stage
Phase 2
Modality
Small Molecules
Administration
Topical, Inhalation, Oral
01

Overview

Eucalyptus oil is a distilled essential oil derived from the leaves of Eucalyptus trees, primarily Eucalyptus globulus. It is widely used for its medicinal properties including as a cough suppressant, decongestant for nasal congestion and asthma, topical analgesic for arthritis and muscular pain, and as an antimicrobial agent. The primary active component in many preparations is 1,8-cineole (eucalyptol), which can comprise up to 80% or more of the oil. Eucalyptus oil exhibits anti-inflammatory effects by modulating immune responses and inhibiting cytokine production in vitro; it also demonstrates antibacterial activity against certain bacterial species. The exact mechanism of action remains incompletely understood but may involve inhibition of prostaglandin and cytokine formation by monocytes[1][2]. Eucalyptol is also commonly used in mouthwashes and cold remedies. Eucalyptus oil must be diluted before use; ingestion at full strength can be toxic[4]. It interacts with several medications metabolized by cytochrome P450 enzymes (CYP1A2/2C19/2C9/3A4) and may lower blood sugar levels when combined with antidiabetic drugs[5][8]. Used both topically and via inhalation; not recommended for oral ingestion due to toxicity risk.

Brand names
fevertreegum treered ironbarkwhite ironbark
Other names
fevertreegum treered ironbarkwhite ironbark
02

Targets

PGN (Peptidoglycan)

Beyond the preview

Go deeper on eucalyptus oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eucalyptus oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call